Two Sigma Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Two Sigma Advisers’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,200	Closed	-$385K	–	2503
2025 Q1	$385K	Sell	29,200 -3,800	-12%	-$52.4K	﹤0.01%	1894
2024 Q4	$521K	Sell	33,000 -13,500	-29%	-$203K	﹤0.01%	1761
2024 Q3	$739K	Sell	46,500 -25,000	-35%	-$402K	﹤0.01%	1545
2024 Q2	$1.09M	Buy	71,500 +2,500	+4%	+$35.8K	﹤0.01%	1508
2024 Q1	$1.01M	Sell	69,000 -213,500	-76%	-$3.12M	﹤0.01%	1576
2023 Q4	$3.93M	Sell	282,500 -336,000	-54%	-$4.49M	0.01%	921
2023 Q3	$8.27M	Sell	618,500 -181,500	-23%	-$2.46M	0.02%	532
2023 Q2	$10.1M	Buy	800,000 +381,500	+91%	+$4.45M	0.03%	481
2023 Q1	$4.77M	Buy	+418,500	New	+$4.52M	0.01%	832
2022 Q4	–	Sell	-26,500	Closed	-$277K	–	2660
2022 Q3	$277K	Sell	26,500 -31,500	-54%	-$335K	﹤0.01%	2074
2022 Q2	$643K	Sell	58,000 -7,000	-11%	-$76.1K	﹤0.01%	1810
2022 Q1	$724K	Buy	+65,000	New	+$737K	﹤0.01%	1804
2021 Q4	–	Sell	-27,500	Closed	-$358K	–	2775
2021 Q3	$358K	Buy	+27,500	New	+$366K	﹤0.01%	2046
2020 Q4	–	Sell	-22,000	Closed	-$306K	–	2549
2020 Q3	$306K	Sell	22,000 -216,000	-91%	-$2.57M	﹤0.01%	2000
2020 Q2	$2.52M	Buy	238,000 +161,500	+211%	+$1.64M	0.01%	1083
2020 Q1	$617K	Sell	76,500 -18,500	-19%	-$154K	﹤0.01%	1708
2019 Q4	$771K	Buy	95,000 +3,000	+3%	+$23.7K	﹤0.01%	1689
2019 Q3	$697K	Sell	92,000 -2,500	-3%	-$18.6K	﹤0.01%	1581
2019 Q2	$708K	Buy	+94,500	New	+$743K	﹤0.01%	1669
2018 Q4	–	Sell	-300,500	Closed	-$2.08M	–	2438
2018 Q3	$2.08M	Sell	300,500 -981,500	-77%	-$6.56M	0.01%	1211
2018 Q2	$8.26M	Buy	1,282,000 +1,245,500	+3,412%	+$7.86M	0.02%	645
2018 Q1	$239K	Buy	+36,500	New	+$256K	﹤0.01%	2092
2016 Q1	–	Sell	-45,000	Closed	-$417K	–	2120
2015 Q4	$417K	Buy	+45,000	New	+$493K	﹤0.01%	1398

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers's RDY Position: Q2 2025 in Review

Two Sigma Advisers sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 29,200 shares — an estimated $385K sold.

Two Sigma Advisers first reported a position in RDY in Q4 2015 and held it in 23 quarters. The position peaked at $10.1M in Q2 2023. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

Two Sigma Advisers reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
Two Sigma Advisers sold 29,200 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $385K.
Two Sigma Advisers first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 23 quarters.
Two Sigma Advisers's Dr. Reddy's Laboratories position peaked at $10.1M in Q2 2023.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.